• Retinoic Acid and Nutrient Restriction Trigger SSC Meiosis

  2026-08-20

  A Methods in Molecular Biology chapter by Zhang and Wang presents a culture strategy in which retinoic acid and nutrient restriction work together to initiate meiotic prophase I in long-term mouse spermatogonial stem cells. The approach addresses a persistent barrier in germline culture and provides a practical framework for studying meiotic entry without assuming that complete spermatogenesis has been achieved in vitro.

• Cefotaxime as a Probe of AMR Transmission

  2026-08-19

  Cefotaxime can do more than benchmark antibacterial activity. Used alongside genotype, plasmid-mobility, and infection-model data, it helps translational researchers connect beta-lactam antibiotic mechanism with the evolving architecture of antimicrobial resistance.

• JTW, Coptisine, and SIRT1 in PCOS Mitochondria

  2026-08-19

  A 2025 Phytomedicine study identifies suppression of SIRT1 ubiquitination as a mechanistic basis for the anti-PCOS activity of Jiao-tai-wan and its constituent coptisine. Using DHEA-induced PCOS rats and primary theca cells, the authors connect SIRT1 protein stability with mitochondrial cholesterol import, StAR localization, and abnormal ovarian steroidogenesis.

• PDK4-IN-1 Hydrochloride: Mechanism & Uses

  2026-08-18

  PDK4-IN-1 hydrochloride is a selective, orally active pyruvate dehydrogenase kinase 4 inhibitor for research on PDH activation and mitochondrial energy metabolism. Product specifications and peer-reviewed findings support its use in in vitro metabolism studies and animal models, while distinguishing vendor-reported properties from evidence for lead compound 8c.

• GDC-0994: Practical ERK1/2 Assay Guidance

  2026-08-18

  This scenario-based guide explains how GDC-0994 (SKU B5817) can support mechanistic studies of ERK-driven proliferation, viability, and cholestatic injury. It covers target engagement, solvent handling, dose design, orthogonal readouts, and practical criteria for selecting a reliable research reagent.

• Ionomycin Free Acid: From Calcium Flux to TNBC Insight

  2026-08-17

  A translational framework for using Ionomycin free acid to interrogate calcium-dependent biology while connecting ionophore workflows with the FAISL–FAK proteolysis axis reported in triple-negative breast cancer.

• SARS-CoV-2 Release: RNAi Maps Rab11a Transport

  2026-08-17

  Kerr et al. used an arrayed, druggable-genome RNA interference screen with virus-production measurements at two timepoints to identify host factors acting across the SARS-CoV-2 replication and reinfection cycle. The study highlights Rab11a-mediated vesicular cargo delivery as a conserved proviral pathway and shows that pharmacological CDK9 inhibition can prevent viral release, providing a framework for host-targeted antiviral research.

• Crizotinib hydrochloride in Gastric Cancer Models

  2026-08-16

  Learn how to use Crizotinib hydrochloride as a pharmacologic probe in matched gastric tumor organoid and stromal assembloid workflows. The approach separates tumor-cell target engagement from microenvironment-driven changes in viability, signaling, and drug sensitivity.

• Omeprazole A2845: H+,K+-ATPase Workflow

  2026-08-15

  Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for controlled gastric acid secretion research, antiulcer activity study design, and related in vitro or ex vivo workflows. Its water and ethanol insolubility requires DMSO-based stock preparation and careful vehicle, precipitation, and stability controls; it is not intended for diagnostic, clinical, or medical use.

• Live-Dead Cell Staining Kit: Calcein-AM/PI Guide

  2026-08-14

  The Live-Dead Cell Staining Kit K2081 uses Calcein-AM and Propidium Iodide to distinguish esterase-active, membrane-intact cells from membrane-compromised cells. This Calcein-AM Propidium Iodide staining workflow supports cell viability assay development in microscopy, flow cytometry, cytotoxicity, and apoptosis research.

• Fenofibrate, PPARα–YAP Signaling in Aging Livers

  2026-08-14

  The reference study demonstrates that Fenofibrate induces comparable liver enlargement and PPARα–YAP pathway activation in adult and aging mice. By combining multiple aging models with morphological and protein-level analyses, it shows that this hepatic response is largely independent of age and provides a framework for evaluating PPARα agonists in gerontological and metabolic research.

• ML-Designed LNPs for Microglia mRNA Delivery

  2026-08-13

  The 2025 Drug Delivery study combined a 216-formulation lipid nanoparticle library with supervised machine learning to predict mRNA transfection and microglial phenotype changes. Its best-performing model identified HA-LNP2, which delivered IL10 mRNA and reduced inflammatory features in both murine and human iPSC-derived microglia, providing a framework for designing carriers that actively contribute to immunomodulation.

• Calnexin-Dependent CFTR Variant Rescue

  2026-08-13

  Tedman et al. used deep mutational scanning to examine how the ER chaperone calnexin shapes expression and corrector responsiveness across 232 clinical CFTR variants. The study shows that calnexin dependence is strongly variant- and domain-specific, providing a mechanistic framework for interpreting heterogeneous responses in cystic fibrosis transmembrane conductance regulator modulation.

• Doxycycline for AAA: From MMP Biology to Delivery

  2026-08-12

  Doxycycline is a tetracycline antibiotic with research value beyond antimicrobial assays, including metalloproteinase inhibition in abdominal aortic aneurysm models. This guide translates targeted nanoparticle findings into practical decisions about controls, formulation, endpoints, and translational interpretation.

• FAISL lncRNA Stabilizes FAK in TNBC Metastasis

  2026-08-12

  The reference study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by preventing Calpain 2-mediated proteolysis in triple-negative breast cancer. Its results connect RNA–protein interaction, focal-adhesion signaling, and metastatic behavior, while also illustrating how reduction-responsive siRNA delivery may be used to test FAISL as a therapeutic target.

8580 records 8/572 page Previous Next First page 上5页 678910 下5页 Last page